XML 19 R5.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Underwriting Agreement
Private Placement
Common Stock
Common Stock
Underwriting Agreement
Common Stock
Private Placement
Additional Paid-In Capital
Additional Paid-In Capital
Underwriting Agreement
Additional Paid-In Capital
Private Placement
Treasury Stock
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021       1,647,555,590                
Beginning balance at Dec. 31, 2021 $ 3,909,355     $ 165     $ 9,995,778     $ (20,716) $ 0 $ (6,065,872)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Net loss (831,812)                     (831,812)
Other comprehensive income (loss) (13,266)                   (13,266)  
Tax withholding payments for net settlement of employee awards (212,895)           (212,895)          
Issuance of common stock upon vesting of employee RSUs (in shares)       13,142,048                
Issuance of common stock upon vesting of employee RSUs 0     $ 1     (1)          
Issuance of common stock under employee stock purchase plan (in shares)       751,036                
Issuance of common stock under employee stock purchase plan 12,882           12,882          
Issuance of common stock upon exercise of stock options (in shares)       18,698,664                
Issuance of common stock upon exercise of stock options 14,738     $ 2     14,736          
Stock-based compensation 352,245           352,245          
Ending balance (in shares) at Sep. 30, 2022       1,680,147,338                
Ending balance at Sep. 30, 2022 3,231,247     $ 168     10,162,745     (20,716) (13,266) (6,897,684)
Beginning balance (in shares) at Jun. 30, 2022       1,672,543,611                
Beginning balance at Jun. 30, 2022 3,710,386     $ 167     10,099,209     (20,716) (691) (6,367,583)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Net loss (530,101)                     (530,101)
Other comprehensive income (loss) (12,575)                   (12,575)  
Tax withholding payments for net settlement of employee awards (21,654)           (21,654)          
Issuance of common stock upon vesting of employee RSUs (in shares)       5,100,389                
Issuance of common stock upon exercise of stock options (in shares)       2,503,338                
Issuance of common stock upon exercise of stock options 1,889     $ 1     1,888          
Stock-based compensation 83,302           83,302          
Ending balance (in shares) at Sep. 30, 2022       1,680,147,338                
Ending balance at Sep. 30, 2022 $ 3,231,247     $ 168     10,162,745     (20,716) (13,266) (6,897,684)
Beginning balance (in shares) at Dec. 31, 2022 1,829,314,736     1,829,314,736                
Beginning balance at Dec. 31, 2022 $ 4,349,701     $ 183     11,752,138     (20,716) (11,572) (7,370,332)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Net loss (2,174,654)                     (2,174,654)
Other comprehensive income (loss) 1,209                   1,209  
Tax withholding payments for net settlement of employee awards (14,705)           (14,705)          
Issuance of common stock upon vesting of employee RSUs (in shares)       11,607,793                
Issuance of common stock upon vesting of employee RSUs 0     $ 2     (2)          
Issuance of common stock under employee stock purchase plan (in shares)       2,287,592                
Issuance of common stock under employee stock purchase plan $ 15,089           15,089          
Issuance of common stock upon exercise of stock options (in shares) 6,827,738     6,827,738                
Issuance of common stock upon exercise of stock options $ 7,321           7,321          
Issuance of common stock under agreement (in shares)         173,544,948 265,693,703            
Issuance of common stock under agreement   $ 1,184,224 $ 1,812,641   $ 17 $ 27   $ 1,184,207 $ 1,812,614      
Stock-based compensation $ 225,189           225,189          
Ending balance (in shares) at Sep. 30, 2023 2,289,276,510     2,289,276,510                
Ending balance at Sep. 30, 2023 $ 5,406,015     $ 229     14,981,851     (20,716) (10,363) (9,544,986)
Beginning balance (in shares) at Jun. 30, 2023       2,282,278,815                
Beginning balance at Jun. 30, 2023 5,959,840     $ 228     14,904,370     (20,716) (9,950) (8,914,092)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Net loss (630,894)                     (630,894)
Other comprehensive income (loss) (413)                   (413)  
Tax withholding payments for net settlement of employee awards (4,327)           (4,327)          
Issuance of common stock upon vesting of employee RSUs (in shares)       5,172,059                
Issuance of common stock upon vesting of employee RSUs 0     $ 1     (1)          
Issuance of common stock upon exercise of stock options (in shares)       1,825,636                
Issuance of common stock upon exercise of stock options 2,214           2,214          
Stock-based compensation $ 79,595           79,595          
Ending balance (in shares) at Sep. 30, 2023 2,289,276,510     2,289,276,510                
Ending balance at Sep. 30, 2023 $ 5,406,015     $ 229     $ 14,981,851     $ (20,716) $ (10,363) $ (9,544,986)